Easton Pharmaceuticals Inc. Aktie Other OTC
Aktien
A1CUUH
US2777741057
EAPH
Biotechnologie
Umsatz 2019 | 1.56 Mio. 1.39 Mio. | Umsatz 2020 | - | Marktwert | 806’959 722’632 |
---|---|---|---|---|---|
Nettoergebnis 2019 | - 0 | Nettoergebnis 2020 | - 0 | EV / Sales 2019 | 6.27 x |
Nettoschuld 2019 | 8.41 Mio. 7.53 Mio. | Nettoschuld 2020 | 2.48 Mio. 2.22 Mio. | EV / Sales 2020 | - |
KGV 2019 |
-4.17
x | KGV 2020 |
-4.29
x | Beschäftigte | - |
Rendite 2019 * |
-
| Rendite 2020 |
-
| Streubesitz | 100% |
Manager | Titel | Alter | Seit |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30.06.15 |
Vince Demasi
COO | Chief Operating Officer | - | 20.06.18 |
Chief Tech/Sci/R&D Officer | - | 01.01.15 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30.06.15 |
John Guerra
SEC | Corporate Secretary | - | 31.12.13 |
Vince Demasi
COO | Chief Operating Officer | - | 20.06.18 |
% 1. Jan. | Kap. | |
---|---|---|
+18.72% | 125 Mrd. | |
+14.19% | 108 Mrd. | |
-4.93% | 24.21 Mrd. | |
+3.23% | 22.78 Mrd. | |
-10.44% | 17.96 Mrd. | |
-41.74% | 16.43 Mrd. | |
-13.31% | 16.37 Mrd. | |
+2.44% | 13.58 Mrd. | |
+27.89% | 11.66 Mrd. |